Jasper Hellweg
Stock Analyst at Argus Research
(2.09)
# 2,838
Out of 5,182 analysts
92
Total ratings
47.22%
Success rate
3.33%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Buy | $360 → $400 | $323.85 | +23.51% | 1 | Feb 6, 2026 | |
| BAX Baxter International | Downgrades: Hold | n/a | $16.62 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $112.68 | +68.62% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $187.21 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $581.22 | -31.18% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $139.37 | +7.63% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $43.35 | +38.41% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $709.21 | +64.97% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $429.85 | +27.95% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $183.46 | -53.67% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $44.39 | +181.59% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $47.30 | +195.98% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $208.16 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $35.35 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $160.94 | +80.19% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $83.95 | +19.12% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $253.01 | +16.60% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.54 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $191.50 | -29.50% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.39 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $172.24 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $228.36 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $29.74 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $427.18 | -63.72% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $62.81 | +43.29% | 1 | Sep 19, 2018 |
Amgen
Feb 6, 2026
Maintains: Buy
Price Target: $360 → $400
Current: $323.85
Upside: +23.51%
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $16.62
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $112.68
Upside: +68.62%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $187.21
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $581.22
Upside: -31.18%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $139.37
Upside: +7.63%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $43.35
Upside: +38.41%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $709.21
Upside: +64.97%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $429.85
Upside: +27.95%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $183.46
Upside: -53.67%
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $44.39
Upside: +181.59%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $47.30
Upside: +195.98%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $208.16
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $35.35
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $160.94
Upside: +80.19%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $83.95
Upside: +19.12%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $253.01
Upside: +16.60%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.54
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $191.50
Upside: -29.50%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $11.39
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $172.24
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $228.36
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $29.74
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $427.18
Upside: -63.72%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $62.81
Upside: +43.29%